| 產(chǎn)品名稱 | KCL22-s |
|---|---|
| 商品貨號(hào) | B161700 |
| Organism | Homo sapiens, human |
| Tissue | pleural effusion, bone marrow |
| Product Format | frozen 1.0 mL |
| Morphology | lymphoblast-like |
| Culture Properties | suspension |
| Biosafety Level | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease | chronic myeloid leukemia at blast crisis |
| Age | 32 years |
| Gender | female |
| Applications | The paired KCL22-s and KCL22-r clones are useful cell line models of sensitivity and resistance to a tyrosine kinase inhibitor used in the treatment of chronic myeloid leukemia. |
| Storage Conditions | liquid nitrogen vapor phase |
| Images |  |
| Comments | BCR-ABL of the e13a2 fusion transcript type. |
| Complete Growth Medium | The base medium for this cell line is RPMI-1640 (ATCC 30-2001). To make the complete medium add to 500 mL of the base medium:
|
| Subculturing | Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 3 X 105 cells/mL and maintain between 1.0 X 105 and 1.5 X 106 cells/mL.
Medium Renewal: Add fresh medium every 2 to 3 days (depending on cell density). |
| Cryopreservation | Complete culture medium + 10% DMSO (ATCC 4-X) |
| Culture Conditions | Atmosphere: air, 95%; carbon dioxide (CO2), 5% CO2
Temperature: 37°C |
| Volume | 1.0 mL |
| STR Profile | Amelogenin: X
CSF1PO: 11,12
D13S317: 8
D16S539:11,12
D5S818: 10,11
D7S820: 12
THO1: 7,9
TPOX: 8
vWA: 14 |
| Sterility Tests | Bacteria and yeast: No growth Mycoplasma: No growth |
| Viral Testing | Hepatitis B: None detected Cytomegalovirus: None detected Human immunodeficiency virus: None detected Epstein-Barr virus: None detected Human papillomavirus: None detected |
| Population Doubling Time | 24 to 30 hours |
| Name of Depositor | J Vaz de Melo, Dept of Hematology, Royal Adelaide Hospital, Australia |
| Year of Origin | 1999 |
| References | Tipping AJ, et al. Comparative gene expression profile of chronic myeloid leukemia cells innately resistant to imatinib mesylate. Exp Hematol 31(11):1073-80, 2003. PubMed: 14585372 Kubonishi I, et al. Establishment of a Ph1 chromosome-positive cell line from chronic myelogenous leukemia in blast crisis. Int J Cell Cloning 1(2):105-17, 1983. PubMed: 3461189 Kubonishi I, et al. Two new Human Myeloid Cell Lines Derived from Acute Promyelo-cytic Leukemia and Chromic myelocytic leukemia. Gan 74: 319-322 1983. PubMed: 6576961 |
| 序號(hào) | 文章標(biāo)題 | 操作 |
|---|---|---|
| 1 | ATCC細(xì)胞運(yùn)輸和處理 | 查看詳情 |
| 2 | 其他海外品牌代理 | 查看詳情 |
| 3 | ATCC代理 | 查看詳情 |
| 4 | 購(gòu)買須知 | 查看詳情 |
| 5 | 訂購(gòu)流程 | 查看詳情 |
| 梅經(jīng)理 | 17280875617 | 1438578920 |
| 胡經(jīng)理 | 13345964880 | 2438244627 |
| 周經(jīng)理 | 17757487661 | 1296385441 |
| 于經(jīng)理 | 18067160830 | 2088210172 |
| 沈經(jīng)理 | 19548299266 | 2662369050 |
| 李經(jīng)理 | 13626845108 | 972239479 |
